BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 24092896)

  • 1. Clinical and magnetic resonance imaging (MRI) distinctions between tumefactive demyelination and brain tumors in children.
    Yiu EM; Laughlin S; Verhey LH; Banwell BL;
    J Child Neurol; 2014 May; 29(5):654-65. PubMed ID: 24092896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solitary tumefactive demyelinating lesions in children.
    Morin MP; Patenaude Y; Sinsky AB; Banwell B; Sébire G
    J Child Neurol; 2011 Aug; 26(8):995-9. PubMed ID: 21555780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and radiological characteristics of tumefactive demyelinating lesions: follow-up study.
    Altintas A; Petek B; Isik N; Terzi M; Bolukbasi F; Tavsanli M; Saip S; Boz C; Aydin T; Arici-Duz O; Ozer F; Siva A
    Mult Scler; 2012 Oct; 18(10):1448-53. PubMed ID: 22419670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric tumefactive demyelination: case series and review of the literature.
    McAdam LC; Blaser SI; Banwell BL
    Pediatr Neurol; 2002 Jan; 26(1):18-25. PubMed ID: 11814730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conventional and advanced magnetic resonance imaging in tumefactive demyelination.
    Saini J; Chatterjee S; Thomas B; Kesavadas C
    Acta Radiol; 2011 Dec; 52(10):1159-68. PubMed ID: 22025739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour-like lesions in multiple sclerosis.
    Jamroz-Wiśniewska A; Janczarek M; Belniak E; Stelmasiak Z; Bartosik-Psujek H
    Neurol Neurochir Pol; 2008; 42(2):161-7. PubMed ID: 18512174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumefactive demyelination: clinical, imaging and follow-up observations in thirty-nine patients.
    Nagappa M; Taly AB; Sinha S; Bharath RD; Mahadevan A; Bindu PS; Saini JS; Prasad C; Shankar SK
    Acta Neurol Scand; 2013 Jul; 128(1):39-47. PubMed ID: 23277913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumefactive demyelinating lesions.
    Dagher AP; Smirniotopoulos J
    Neuroradiology; 1996 Aug; 38(6):560-5. PubMed ID: 8880719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of pediatric tumefactive demyelinating lesion misdiagnosed and treated as glioblastoma.
    Riva D; Chiapparini L; Pollo B; Balestrini MR; Massimino M; Milani N
    J Child Neurol; 2008 Aug; 23(8):944-7. PubMed ID: 18344459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolated tumefactive demyelinating lesions: diagnosis and long-term evolution of 16 patients in a multicentric study.
    Siri A; Carra-Dalliere C; Ayrignac X; Pelletier J; Audoin B; Pittion-Vouyovitch S; Debouverie M; Lionnet C; Viala F; Sablot D; Brassat D; Ouallet JC; Ruet A; Brochet B; Taillandier L; Bauchet L; Derache N; Defer G; Cabre P; de Seze J; Lebrun Frenay C; Cohen M; Labauge P
    J Neurol; 2015 Jul; 262(7):1637-45. PubMed ID: 25929666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paraneoplastic tumefactive demyelination with underlying combined germ cell cancer.
    Broadfoot JR; Archer HA; Coulthard E; Appelman AP; Sutak J; Braybrooke JP; Love S
    Pract Neurol; 2015 Dec; 15(6):451-5. PubMed ID: 26088612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI parameters for prediction of multiple sclerosis diagnosis in children with acute CNS demyelination: a prospective national cohort study.
    Verhey LH; Branson HM; Shroff MM; Callen DJ; Sled JG; Narayanan S; Sadovnick AD; Bar-Or A; Arnold DL; Marrie RA; Banwell B;
    Lancet Neurol; 2011 Dec; 10(12):1065-73. PubMed ID: 22067635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumefactive demyelination of the spinal cord.
    Yaghi S; Gokdin M; Sethi H
    Acta Neurol Belg; 2010 Jun; 110(2):206-8. PubMed ID: 20873455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biopsy-Supported Tumefactive Demyelination of the Central Nervous System in Children.
    Hanumanthe SB; Francisco C; Hart J; Graves J; Waubant E
    J Child Neurol; 2016 Dec; 31(14):1528-1533. PubMed ID: 27572815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mass lesions in the brain: tumor or multiple sclerosis? Clinical and imaging characteristics and course from a single reference center.
    Kilic AK; Kurne AT; Oguz KK; Soylemezoglu F; Karabudak R
    Turk Neurosurg; 2013; 23(6):728-35. PubMed ID: 24310455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large focal tumor-like demyelinating lesions of the brain: intermediate entity between multiple sclerosis and acute disseminated encephalomyelitis? A study of 31 patients.
    Kepes JJ
    Ann Neurol; 1993 Jan; 33(1):18-27. PubMed ID: 8494332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monophasic, solitary tumefactive demyelinating lesion: neuroimaging features and neuropathological diagnosis.
    Tan HM; Chan LL; Chuah KL; Goh NS; Tang KK
    Br J Radiol; 2004 Feb; 77(914):153-6. PubMed ID: 15010391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumefactive demyelinating lesions: A comprehensive review.
    Algahtani H; Shirah B; Alassiri A
    Mult Scler Relat Disord; 2017 May; 14():72-79. PubMed ID: 28619436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinguishing tumefactive demyelinating lesions from glioma or central nervous system lymphoma: added value of unenhanced CT compared with conventional contrast-enhanced MR imaging.
    Kim DS; Na DG; Kim KH; Kim JH; Kim E; Yun BL; Chang KH
    Radiology; 2009 May; 251(2):467-75. PubMed ID: 19261924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent tumefactive demyelination in a child.
    Puri V; Chaudhry N; Gulati P; Tatke M; Singh D
    J Clin Neurosci; 2005 May; 12(4):495-500. PubMed ID: 15925795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.